Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. - Gebler C; Lohoff T; Paszkowski-Rogacz M; Mircetic J; Chakraborty D; Camgoz A; Hamann MV; Theis M; Thiede C; Buchholz F (Journal of the National Cancer Institute, 2016)